- Home
- ESP vs IKT Comparison
ESP vs IKT Comparison
Compare ESP & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- IKT
- Stock Information
- Founded
- ESP 1928
- IKT 2008
- Country
- ESP United States
- IKT United States
- Employees
- ESP N/A
- IKT N/A
- Industry
- ESP Industrial Machinery/Components
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- IKT Health Care
- Exchange
- ESP Nasdaq
- IKT Nasdaq
- Market Cap
- ESP 129.5M
- IKT 140.5M
- IPO Year
- ESP N/A
- IKT 2020
- Fundamental
- Price
- ESP $47.61
- IKT $1.85
- Analyst Decision
- ESP
- IKT Buy
- Analyst Count
- ESP 0
- IKT 2
- Target Price
- ESP N/A
- IKT $8.00
- AVG Volume (30 Days)
- ESP 29.3K
- IKT 526.2K
- Earning Date
- ESP 05-12-2025
- IKT 08-13-2025
- Dividend Yield
- ESP 2.11%
- IKT N/A
- EPS Growth
- ESP 39.20
- IKT N/A
- EPS
- ESP 2.67
- IKT N/A
- Revenue
- ESP $45,965,588.00
- IKT N/A
- Revenue This Year
- ESP N/A
- IKT N/A
- Revenue Next Year
- ESP N/A
- IKT N/A
- P/E Ratio
- ESP $17.72
- IKT N/A
- Revenue Growth
- ESP 29.60
- IKT N/A
- 52 Week Low
- ESP $20.50
- IKT $1.12
- 52 Week High
- ESP $49.00
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- ESP 73.32
- IKT 47.71
- Support Level
- ESP $45.94
- IKT $1.80
- Resistance Level
- ESP $48.24
- IKT $2.09
- Average True Range (ATR)
- ESP 1.97
- IKT 0.14
- MACD
- ESP 0.13
- IKT 0.03
- Stochastic Oscillator
- ESP 90.14
- IKT 54.72
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.